Geisinger Medical Laboratories Test Catalog
IGF BINDING PROTEIN-2 |
||
Geisinger Epic Procedure Code: LAB1203
Geisinger Epic ID: 52737
|
||
SPECIMEN COLLECTION |
||
Specimen type: |
Serum | |
Preferred collection container: |
||
Alternate Collection Container: |
6 mL red-top (plain, non-serum separator) tube
|
|
Specimen required: |
1 mL serum; minimum 0.2 mL. | |
Patient preparation: |
Fasting is preferred. | |
SPECIMEN PROCESSING |
||
Specimen processing instructions: |
Centrifuge and aliquot. | |
Transport temperature: |
Refrigerated (cold packs). | |
Specimen stability: |
Room temperature: 12 hours. Refrigerated: 4 days. Frozen: 28 days. | |
Rejection criteria: |
Gross hemolysis • Gross lipemia • Received room temperature | |
TEST DETAILS |
||
Additional information: |
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes. | |
CPT code(s): |
83519 | |
Note: The billing party has sole responsibility for CPT coding. Any questions regarding coding should be directed to the payer being billed. The CPT codes provided by GML are based on AMA guidelines and are for informational purposes only. | ||
Methodology: |
Radioimmunoassay (RIA) |
|
Synonyms: |
Quest test code 70782, IGF BP 2, Insulin-Like Growth Factor Binding Protein-2,Somatomedin-C Binding Protein-2 ,Binding Protein-2,IGFBP-2
|
|
Clinical significance: |
The concentration of IGFBP-2 is inversely correlated with changes in growth hormone (hGH) secretion. IGFBP-2 may also be used as a marker of metastatic prostatic carcinoma. |